On average, analysts expect that Healthequity will report full year earnings of $0.53 per share for the current fiscal year, with EPS estimates ranging from $0.51 to $0.56. For the next financial year, analysts expect that the company will post earnings of $0.71 per share, with EPS estimates ranging from $0.61 to $0.76. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Healthequity.
Wall Street brokerages expect Healthequity Inc (NASDAQ:HQY) to report earnings per share (EPS) of $0.16 for the current quarter, according to Zacks. Eight analysts have issued estimates for Healthequity’s earnings, with estimates ranging from $0.15 to $0.17. Healthequity reported earnings per share of $0.14 during the same quarter last year, which suggests a positive year-over-year growth rate of 14.3%. The company is expected to announce its next earnings report on Tuesday, June 6th.
Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, March 21st. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. Healthequity had a net margin of 15.19% and a return on equity of 11.08%. The firm earned $46.83 million during the quarter, compared to the consensus estimate of $45.55 million. During the same period in the previous year, the firm earned $0.07 earnings per share. Healthequity’s revenue was up 30.4% compared to the same quarter last year. Several brokerages recently weighed in on HQY. Zacks Investment Research raised shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Saturday, March 4th. Chardan Capital reaffirmed a “buy” rating and set a $47.00 price objective on shares of Healthequity in a research report on Tuesday, February 7th. FIX began coverage on shares of Healthequity in a research report on Tuesday, March 14th. They set an “outperform” rating on the stock. Oppenheimer Holdings Inc. began coverage on shares of Healthequity in a research report on Monday, March 13th. They set an “outperform” rating and a $58.00 price objective on the stock. Finally, KeyCorp began coverage on shares of Healthequity in a research report on Monday, January 23rd. They set an “overweight” rating and a $60.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Healthequity has an average rating of “Buy” and an average price target of $45.18.
Healthequity (NASDAQ:HQY) traded up 0.15% during midday trading on Wednesday, reaching $46.18. 325,863 shares of the company were exchanged. The stock has a market capitalization of $2.75 billion, a price-to-earnings ratio of 104.95 and a beta of 1.94. The firm’s 50-day moving average price is $43.60 and its 200 day moving average price is $42.21. Healthequity has a 52-week low of $22.26 and a 52-week high of $49.25. In related news, Director Adrian T. Dillon purchased 5,000 shares of the stock in a transaction on Thursday, March 30th. The shares were bought at an average price of $40.53 per share, for a total transaction of $202,650.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Darcy G. Mott sold 10,000 shares of the stock in a transaction that occurred on Tuesday, February 21st. The shares were sold at an average price of $42.60, for a total value of $426,000.00. Following the transaction, the chief financial officer now owns 74,000 shares in the company, valued at approximately $3,152,400. The disclosure for this sale can be found here. In the last quarter, insiders have sold 282,765 shares of company stock worth $12,699,478. Corporate insiders own 29.00% of the company’s stock.
Healthequity Company Profile HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Get a free copy of the Zacks research report on Healthequity (HQY) For more information about research offerings from Zacks Investment Research, visit Zacks.com